Seventeen units set to begin operations in Ujjain from new fiscal year

Indore: As many as 17 manufacturing units with a combined investment of around Rs 1,700 crore are set to begin operations in Ujjain from new financial year, a move expected to generate employment for more than 4,000 people.The units are coming up across two major industrial clusters in district – Vikram Udyogpuri and Medical Device Park, both developed under Delhi–Mumbai Industrial Corridor (DMIC) framework.Of the total, nine units are scheduled to start production in Vikram Udyogpuri alone. The largest among them is PepsiCo India Holdings Pvt Ltd, which is setting up a Rs 1,225-crore facility to manufacture beverage flavouring ingredients. The plant is already ready for operations, officials said. "With infrastructure and policy support in place, Vikram Udyogpuri and Medical Device Park are emerging as important manufacturing hubs. The projects will create large-scale employment for local youth and strengthen Ujjain's position as an industrial centre in the state," MPIDC executive director Rajesh Rathod said.Other companies in the cluster include Simplico Industries Pvt Ltd, which will manufacture eco-friendly paper plates, JK Lifecare Centres and Chemerix Life Sciences Pvt Ltd in the pharmaceutical segment, and QuantSolar Technologies, which will produce industrial plastic tanks and boxes.Food processing unit Maheshwari Ke Namkeen will manufacture snacks and sweets, while Playgro Toys India Pvt Ltd will produce toys and children's furniture. Engineering units such as Metal Forger and Fabricators and Skyline Industries Pvt Ltd will manufacture engine components, cranes and industrial machinery.Together, Vikram Udyogpuri units account for an investment of about Rs 1,360 crore and are expected to generate employment for more than 1,700 people.Eight units are set to start production at Medical Device Park, largely focused on healthcare equipment manufacturing.These include CliniSupplies India Pvt Ltd, which will manufacture catheters and medical devices, VRM Molecular and Nuclear Medicines Pvt Ltd in specialised pharmaceuticals, and HC Lifeline, which will produce syringes and cannulas.Other upcoming units include KRM Healthcare, Microgen Healthcare, Meepl Technologies, Shreeji Polymers Medical Devices and Bioline India, producing items such as testing kits, orthopaedic implants, insulin devices, blood bags and infection-prevention products.The eight units together represent an investment of about Rs 254 crore and are expected to employ around 2,400 people.